...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Tensha Therapeutics sold to Roche
Today Tensha Therapeutics was sold to Roche for USD 115 million plus additional 420 million in contingent payments. Best regards, BKC
Share
New Message
Please login to post a reply